Autopsy report · NCT00547404

Phase I Study for Safety and Efficacy of P276-00 in Subjects With Myeloma

“Not to expose the patients to subtherapeutic dose”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

Piramal Enterprises Limited

Sponsor type

Industry

Conditions

Multiple Myeloma

Interventions

P276-00

Participants

35 (planned, not actual)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.